Prem Sahasranam

Whiterabbit.ai was founded in 2017 to significantly reduce late-stage cancers by detecting them in their earliest stages, starting with breast cancer. We are developing a state-of-the-art artificial intelligence (AI) suite to improve: Breast cancer screening rates Radiologists’ accuracy, productivity, and workflow Clinic operations to ensure patients receive timely and compassionate care The patient experience through a mobile app that gives the consumer access to their medical images with the ability to instantly share Nearly forty million women get mammograms every year in the US. About 1 in 8 women will develop invasive breast cancer over the course of her lifetime. We hope through developing robust AI technologies, we can improve the speed and accuracy of cancer detection in radiology. Our solutions in development are aimed at redesigning the entire breast cancer screening process with a focus on compassion. Through redefining and shortening the screening and diagnosis experience for women, we aim to improve their patient experiences and outcomes. Training AI to solve complex problems requires a robust data set. Whiterabbit and The Mallinckrodt Institute of Radiology at Washington University School of Medicine have forged a collaboration to build a world-class data set and lead the advancement of breast cancer detection with machine learning.

Why was My Diabetes Tutor founded? Dr. Prem Sahasranam, who goes by Dr. Sahas, is a Board-Certified Endocrinologist and the Founder of My Diabetes Tutor. He founded Central Valley Endocrinology in 2007, a state-of-the-art endocrine practice in Central California that provides exceptional care for adults in the rural Hanford-Visalia area which serves half a million people. He discovered that diabetes occurs at higher rates in rural versus urban areas, and people living in these rural areas have more diabetes-related complications. This scenario motivated Dr. Sahas to establish My Diabetes Tutor, Inc. (MDT) in September 2020 to bridge the gap in diabetes education, because with appropriate self-management education and support, people with diabetes can learn how to manage their diabetes, thereby preventing such complications. What does My Diabetes Tutor do? MDT is a nationally accredited, 1:1 Diabetes Self-Management Education and Support (DSMES) telehealth solution. It is the first program to provide in-patient diabetes education on-call services. It collaborates with health plans, health systems, and providers to deliver coaching to patients in the privacy of their own homes or via health provider kiosks. The program also has a diabetes prevention program, remote patient monitoring, and weight management program under development. Is it working? MDT outcomes have outpaced the national average for DSMES, delivering an average 1.6 A1C reduction for patients. Is MDT covered by insurance? MDT is 100% covered by Medicare and covered by most insurance providers in California. What does the future look like for MDT? After showing positive outcomes in rural Central California, MDT is expanding to address a great need to make diabetes education accessible in other rural communities. How can My Diabetes Tutor help your practice and patients? Visit https://mydiabetestutor.com or email us at info@mydiabetestutor.com to find out.

Whiterabbit.ai was founded in 2017 to significantly reduce late-stage cancers by detecting them in their earliest stages, starting with breast cancer. We are developing a state-of-the-art artificial intelligence (AI) suite to improve: Breast cancer screening rates Radiologists’ accuracy, productivity, and workflow Clinic operations to ensure patients receive timely and compassionate care The patient experience through a mobile app that gives the consumer access to their medical images with the ability to instantly share Nearly forty million women get mammograms every year in the US. About 1 in 8 women will develop invasive breast cancer over the course of her lifetime. We hope through developing robust AI technologies, we can improve the speed and accuracy of cancer detection in radiology. Our solutions in development are aimed at redesigning the entire breast cancer screening process with a focus on compassion. Through redefining and shortening the screening and diagnosis experience for women, we aim to improve their patient experiences and outcomes. Training AI to solve complex problems requires a robust data set. Whiterabbit and The Mallinckrodt Institute of Radiology at Washington University School of Medicine have forged a collaboration to build a world-class data set and lead the advancement of breast cancer detection with machine learning.

Charles R. Drew University of Medicine and Science (CDU) is a private, nonprofit, nonsectarian, medical and health sciences institution. Located in the Watts-Willowbrook area of South Los Angeles, CDU has graduated more than 550 medical doctors, 2,500 post-graduate physicians, more than 2,000 physician assistants and hundreds of other health professionals. CDU has earned designation as a minority-serving institution by the U.S. Office of Civil Rights, and its College of Medicine (COM) is recognized by the Department of Education (DOE) as a Historically Black Graduate Institution (HBGI as designated by Title III B). The University is a charter member of the Hispanic Serving Health Professions Schools, a national nonprofit dedicated to improving the health of Hispanic people through research initiatives, training opportunities, and academic development. CDU’s mission is to conduct education, research and clinical services in the context of community engagement to train health professionals who promote wellness, provide care with excellence and compassion, and transform the health of underserved communities. CDU has evolved and grown, shaped by the needs of the community it serves. The institution benefits from its location and the corresponding diversity and complexity of its population by creating an academic environment unlike any other. Following nearly a decade of community-based advocacy for improved medical services, Charles R. Drew Postgraduate Medical School was incorporated in August of 1966. In response to the lack of adequate medical facilities in the area, the institution later became a University and changed its name in1987 to reflect its expanded academic role and identity. The University is named in honor of Dr. Charles R. Drew, a brilliant African-American physician, famous for his pioneering work in blood preservation. His dedication to learning and sharing knowledge to benefit mankind is the inspiration for the University.